Granuloma Annulare: Long-term Follow-up G ranuloma annulare is a peculiar skin disorder of unknown cause. 1 Asymptomatic, annular, skin-colored to violaceous papules and plaques mysteriously erupt on nonfacial skin, usually without any obvious cause. A loose collection of histiocytes surrounds or infiltrates a more amorphous and rather acellular zone of degenerated connective tissue and mucin. Often the disorder resolves with or without treatment.
Perhaps inflammation is aberrant, [2] [3] [4] and the nature of inflammation differs from person to person, based on some genetic perturbation. Perhaps an "ordinary" event such as a tuberculin skin test, trauma, infection, insect bite, or sun exposure starts an inflammation that deviates from its usual path and morphs into a persisting necrobiotic granuloma instead of resolving. Based on this hypothesis, one might predict that patients with granuloma annulare would develop other bizarre inflammatory disorders or odd sequelae, even many years later. Perhaps they might even die from an odd disease or disorder.
Methods.
To test this prediction, we identified the Mayo Clinic records of patients with granuloma annulare. The institutional review board approved a retrospective medical chart review of these records in a study designed to survey the development of subsequent disease among affected patients. The study was a qualitative pilot study. No attempt was made to age-or sex-match subjects.
The study group consisted of 32 patients with granuloma annulare seen at Mayo Clinic between 1950 and 1970. All subjects had follow-up visits at Mayo Clinic for at least 20 years. The charts were screened for unusual diseases and for diseases related to connective tissue, odd inflammations, or unusual diseases. There were 21 female and 11 male subjects. The average age at diagnosis was 48 years (age range, 4-58 years). Only 3 were children younger than 12 years. The mean follow-up was 35 years (follow-up range, 20-53 years). 
Overexpression of Matrix Metalloproteinases, Chemokines, and Chemokine Receptors Relevant for Metastasis in Experimental Models Not an Indication of Lymph Node Metastases in Human Melanoma
M orphologic characteristics such as tumor thickness and ulceration are the major accepted indicators of risk for metastatic spread. Since matrix metalloproteinases and chemokines and their receptors are involved in the complex process of metastasis, we tested whether their expression predicts the risk of melanoma progression. To this end, the relative messenger RNA (mRNA) expression of chemokine receptors CCR7 and CXCR4, the chemokine CXCL8, and the matrix metalloproteinases MMP2 and MT1-MMP in primary cutaneous melanomas from 28 patients was correlated with the presence of micrometastases in the respective sentinel lymph nodes.
Methods.
We gained approval from our local ethics committee, and analyses were performed with the patients' informed consent. Primary tumors were trimmed to remove most of the surrounding unaffected skin, and total RNA was isolated from frozen tissue sections. After complementary DNA was generated from this RNA, relative expression of CCR7, CXCR4, CXCL8, MMP2, and MT1-MMP was determined by real-time polymerase chain reaction and the comparative delta-delta threshold cycle (⌬⌬C T ) method where glyceraldehyde-3-phosphate dehydrogenase served as endogenous control. The results were statistically tested after log-normal transformation using the 2-tailed nonpaired t test.
Results. For CXCR4 (P=.01) and MMP2 (P =.04), an inverse relationship between mRNA expression and presence of lymph node metastases was detected (Figure) . Primary tumors associated with concurrent lymph node metastasis, while not reaching statistical significance, also showed lower expression of CCR7 (P = .06) and MT1-MMP (P =.09). For CXCL8 (P =.96), no correlation was observed.
Comment. The statistically significant inverse correlation of the expression of genes known to promote metastasis (CXCR4 and MMP2) and the presence of lymph node micrometastases was unexpected. For example, Mü ller et al 1 detected an increased expression of CXCR4 and CCR7 in human melanoma cells compared with primary melanocytes. In a murine melanoma model, however, CXCR4 expression did not enhance occurrence of lymph node metastasis. 2 Notably, cell signaling is influenced not only by the amount of expressed chemokine receptors or their ligands but also through regulatory mechanisms. Indeed, despite high expression of CXCR4 on germinal center T cells, their migration to CXCL12 was diminished owing to follicular dendritic cell-mediated expression of regulators of G protein signaling 13 and 16. 3 In addition, tumor cells are highly flexible, ie, they can change from proteolytic migration to proteolysis-independent movement in an ameboid manner. 4 Furthermore, heterogeneity of tissues has to be taken into account; in contrast to tumor cell lines, tumors consist of different proportions of tumor, fibrocytic, vascular, and inflammatory cells. Therefore, the variances in mRNA expression could partly be due to variances in cell composition. Thus, polymerase chain reaction analyses of microdissection samples should reflect the cytokine expression in single cells more accurately.
Nevertheless, since tumor cells and surrounding host cells form a complex environment, the investigation of the whole tumor is in accordance with physiologic conditions. Such an analysis, however, forecloses identification of individual cells characterized by overexpression of a given mRNA, which may be essential for the metastatic potential. In addition, similar RNA levels may result in different protein expression by differences in the protein turnover, ie, translation and degradation. Therefore, our results do not exclude the relevance of the in- 
